Aliso Viejo, CA, June 05, 2018 (GLOBE NEWSWIRE) — OrthAlign, Inc., a privately held U.S. based medical device and technology company providing orthopedic surgeons with advanced precision technologies, announced another milestone achievement in its 2,000^th HipAlign case. HipAlign was commercially launched in early 2018 for direct anterior total hip replacement.

HipAlign acts as a GPS for surgeons, using micro-electromechanical sensors like accelerometers and gyroscopes to guide hip replacement surgery, ensuring accuracy and alignment in cup placement and in tracking changes in leg-length. All of this happens in a phone-like device that sits in the surgeon’s hands and on their surgical instruments.

“We are excited to reach this milestone after a diligent limited-market release throughout 2017 and a full-launch following the AAOS annual meeting earlier this year,” said Eric B. Timko, Chief Executive Officer and Chairman of OrthAlign. “HipAlign’s rapid adoption proves there is high demand for a cost effective, minimally disruptive technology that provides increased accuracy and consistency in total hip replacements. With HipAlign, we’re able to expand our orthopedic offering and continue to provide surgeons and healthcare facilities clinically beneficial and economically friendly technologies.”

“After performing over 3,000 navigated total hip arthroplasties using a variety of different navigation devices and techniques, HipAlign has fit my workflow and made my accuracy the best by far,” said Dr. Matthew Heinrich, Orthopedic Surgeon at the Texas Institute for Hip and Knee Surgery. “I said goodbye to lead aprons due to a minimal x-ray need for my anterior total hips. My clinical results have been excellent. I have found the lower cost technique is easily portable, and have used it at five different facilities, including two surgery centers where I perform outpatient total hips.  My patients also appreciate that I utilize technology to help make sure that my accuracy is second to none!”

With no pre-operative CT-scan required, HipAlign delivers results without disruption. Patients receive the benefits of computer-guided surgery without additional time spent for pre-operative imaging procedures. With HipAlign, anatomic data is collected by the surgeon during the procedure, providing information not previously available using traditional hip surgery approaches.

About OrthAlign, Inc.

OrthAlign is a privately held medical device and technology company, developing advanced technologies that deliver healthier and more pain-free lifestyles to joint replacement patients, globally. We provide healthcare professionals with cutting edge, computer-assisted surgical tools that seamlessly and cost-effectively deliver vital data and clinical results to optimize outcomes for our patients. For more information regarding OrthAlign, please visit www.orthalign.com.

“ORTHALIGN®, ORTHALIGN PLUS®, KNEEALIGN®, KNEEALIGN® 2, HIPALIGN® and UNIALIGN™ are registered trademarks of OrthAlign, Inc.

Adam Simone
OrthAlign
asimone@orthalign.com

ATLANTA, May 25, 2018 /PRNewswire/ — OrthoAtlanta orthopedic surgeons Michael J. Behr, M.D., and Peter J. Symbas, M.D., are two sports medicine physicians who have dedicated their careers to serving others, treating Atlanta-area patients with the most complex sports injuries, including those in need of total joint repair and joint replacement surgeries. These dedicated medical professionals are also known for generous donation of their time and talents to those in need in some of the most impoverished parts of the world. Dr. Behr and Dr. Symbas recently returned from a week-long medical mission trip in Honduras where their total joint replacement expertise contributed to a first-of-its-kind orthopedic surgical effort at Holy Family Surgery Center in May 2018.

As part of a brigade of 37 volunteer medical professionals specially trained in orthopedic surgery and surgical support, the Georgia-based team, including five orthopedic surgeons, surgical nurses and medical specialists, completed thirty-seven (37) total knee replacement surgeries in three days. This number was nearly one-third the total number of knee replacements performed the previous year throughout the entire country.

The remarkable Atlanta-based team traveled to Honduras as part of One World Surgery, a non-profit organization that founded and runs Holy Family Surgery Center in Honduras. Approximately one hour northeast of Tegucigalpa, the capital of Honduras, the surgery center is located on the property of Nuestros Pequeños Hermanos (NPH), a 2,000-acre ranch that serves as a loving home for some 500 orphaned, abandoned and disadvantaged children in Honduras. Providing educational and technical training for the youth, it’s a testament to the organization’s mission of sustainability and giving back that nearly half of the surgery center staff were NPH residents at one time. Surgeries at the center are needs-based and provided to pre-qualified patients of all ages.

Supplementing the services of this surgery center, One World Surgery coordinates brigades of volunteer medical experts for week-long service. Prior brigades have included heart surgery, OB/GYN and ophthalmology. Although orthopedic specialists have served the organization in the past, the Atlanta-based team, who have coined the name OneJoint, enabled the first-ever focused effort on total knee replacement specifically.

Preparation for the Georgia-based orthopedics team endeavor was many months in the planning. Crosslink Orthopedics, a local medical equipment supply company based in Norcross, Georgia, donated all the medical hardware for the joint replacements. Thomas Fleetwood from Crosslink reached out to orthopedic surgeons from several of Georgia’s leading orthopedic and sports medicine practices, including Dr. Symbas and Dr. Behr of OrthoAtlanta. Additional team members included skilled OR and post-operative nurses and medical technicians bringing the entire operating brigade to 37 people. The trip was entirely self-funded, from initial registration fees and flights to extra baggage fees needed for some 20 crates of equipment and supplies.

A practicing orthopedic surgeon with OrthoAtlanta for over 25 years, Michael J. Behr, M.D., has served on other medical mission trips in the past, including an Atlanta-based orthopedic group serving the country of Haiti. Dr. Behr’s first trip to Haiti was in 2010, the year of the deadly earthquake that killed thousands of people and left so much of the island in ruins. Inspired by the people of Haiti and the medical needs that continue today, Dr. Behr recently completed his ninth trip to Haiti in February 2018.

Dr. Behr, who today serves as the OrthoAtlanta medical director, shared insights into his draw to Haiti, and now Honduras. Dr. Behr said, “Impoverishment in Latin America, Central and South America is real and there is an ongoing need for quality medical care. The ability to return an individual in Honduras to a highly functional level with a ‘new knee’ does more than improve one individual’s quality of life – it affects the whole family and often an entire community.”

Peter J. Symbas, M.D., an OrthoAtlanta orthopedic surgeon with subspecialty certification in sports medicine, has also served on other medical mission trips, including a trip to Haiti in 2017. When asked why he goes on mission trips, Dr. Symbas commented, “I get so much more out of these trips than even the many people whose lives we touch. Nothing is more rewarding than the smiles we receive in return.” Dr. Symbas, who sees patients at OrthoAtlanta offices including Piedmont West, Kennesaw and Marietta, also serves as the chief medical officer for Atlanta United FC, Atlanta’sprofessional soccer team and is the chief of orthopedics for the Piedmont Clinic for Piedmont Healthcare.

The Atlanta-based team of orthopedics professionals who recently returned from a week’s accomplishments in Honduras is committed to returning to the country in 2019 as part of a sustained, long-term effort to provide orthopedic service to the Honduran people. Watch for future information about their upcoming commitment to service.

About OrthoAtlanta
OrthoAtlanta is one of the largest physician-owned orthopedic and sports medicine practices in the greater Atlanta, Georgia, area providing an integrated approach to delivering musculoskeletal care. With 38 physicians serving in 14 offices, the practice provides the highest level of patient care for injury or deformity of muscles, joints, bones and spine. OrthoAtlanta offers convenient accessibility to a full range of musculoskeletal surgeons, specialists and patient services including on-site physical therapy, pain management care, seven MRI imaging centers and workers’ compensation coordination. OrthoAtlanta Surgery Centers in Austell and Fayetteville provide cost-effective, same-day surgical procedures in an accredited outpatient center. Comprehensive operative and non-operative musculoskeletal care and expertise includes sports medicine, arthroscopic surgery, hip replacement, knee replacement, neck and spine surgery, elbow and shoulder surgery, hand and wrist surgery, foot and ankle surgery, physical medicine and rehabilitation, arthritis treatment, general orthopedics, work-related injuries and acute orthopedic urgent care.

Learn more at www.OrthoAtlanta.com.

For additional information, please contact Pat Prosser, Public Relations Manager, at OrthoAtlanta, 678-996-7254, or via email pprosser@OrthoAtlanta.com.

WARSAW, Ind., May 22, 2018 /PRNewswire/ — DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today announces the U.S. launch of the GLOBAL UNITE Reverse Fracture Shoulder, an innovative implant solution for shoulder reconstruction following complex fractures in patients with a grossly deficient rotator cuff. The new system is designed to provide increased flexibility for securely reattaching the bone to the implant, which is important for healing and function, and allowing biological fixation to the stem of the implant with a porous coating to help deliver a consistent surgical outcome. This new offering adds to DePuy Synthes’ commitment to innovative shoulder solutions that address the full continuum of shoulder disorders.

Shoulder fractures are the second most common fracture of the upper extremity, representing 10 percent of all fractures in those older than 65 years and are increasing in frequency as the elderly population grows.¹ When patients with grossly deficient rotator cuffs suffer 3- or 4-part fractures in the upper arm bone (proximal humerus), it is often challenging to provide consistent treatment that helps healing and restores motion. Increasingly, surgeons are shifting to a reverse shoulder implant for more consistent and predictable outcomes for these patients.²

“I find that especially in my older patients whose bone quality doesn’t allow me to use the plates and screws typically used in a shoulder fracture procedure, fixation is an issue often due to weak rotator cuffs,” said Dr. Carl Basamania***, Orthopaedic Surgeon. “In my experience with the GLOBAL UNITE Reverse Fracture Shoulder System I get strong fixation and I feel a lot more confident about moving patients early so they get better motion and a quicker return to function.”

In a reverse total shoulder replacement, the ball and socket anatomy is reversed. A metal ball is fixed to the shoulder socket and a cup is fixed to the upper end of the humerus. Instead of using the rotator cuff to power the shoulder, the implant uses the deltoid muscle, which is the muscle at the top of the arm and shoulder.

The GLOBAL UNITE Reverse Fracture Shoulder provides:

• Numerous suture holes, designed in the collar on top of the implant, and suture pockets around the backside of the implant to enhance bone fixation around the implant.
• POROCOAT Porous Coating, a proprietary technology that consists of microscopic titanium beads. The porous structure supports biological fixation at the bone-implant interface.³
• Backside pockets specially designed for bone graft, which may help promote bone growth and healing.
• A streamlined instrumentation kit that is designed to improve cross compatibility across DePuy Synthes’ shoulder offerings.

“DePuy Synthes’ broad portfolio of shoulder solutions helps surgeons address a wide range of conditions from traumatic shoulder fractures to rotator cuff tears and instability,” said Stephanie Chamberlain, Global Platform Leader Mitek Sports Medicine and Shoulder. “We offer solutions for minimally invasive surgery and complete shoulder reconstruction, all designed to restore mobility for patients.”

The GLOBAL UNITE Reverse Fracture Shoulder is the latest implant offering under our GLOBAL UNITE Platform Shoulder System and builds on the company’s long history in innovative shoulder reconstruction. This includes the DELTA XTEND Reverse Shoulder System and most recently the launch of TRUMATCH Personalized Solutions Shoulder System pre-surgical planning software for shoulder reconstruction, which can be used in both reverse and anatomic total shoulder arthroplasty to optimize implant positioning and placement.

The GLOBAL UNITE Reverse Fracture Shoulder will launch in the U.S. beginning in the 2018 second quarter. For more information click here.

About the Johnson & Johnson Medical Devices Companies

The Johnson & Johnson Medical Devices Companies’ purpose is to reach more patients and restore more lives. Having advanced patient care for more than a century, these companies represent an unparalleled breadth of products, services, programs and research and development capabilities in surgical technology, orthopaedics, interventional solutions and specialty surgery with an offering directed at delivering clinical and economic value to health care systems worldwide.

About DePuy Synthes

DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, provides one of the most comprehensive orthopaedics portfolios in the world. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information, visit www.depuysynthes.com.

*DePuy Synthes represents the products and services of DePuy Synthes, Inc. and DePuy Orthopaedics, Inc.

**The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopaedics, and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment.

***Dr. Carl Basamania is a consultant to DePuy Synthes Joint Reconstruction.

Cautions Concerning Forward-Looking Statements

This press release contains “forward-looking statements,” as defined in the Private Securities Litigation Reform Act of 1995, regarding the roll out of the GLOBAL UNITE™ Reverse Fracture Epiphysis (FX) Shoulder System. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of DePuy Synthes, Inc., any of the other Johnson & Johnson Medical Devices Companies and/or Johnson & Johnson.  Risks and uncertainties include, but are not limited to: uncertainty of commercial success; competition, including technological advances, new products and patents attained by competitors; challenges to patents; product efficacy or safety concerns resulting in product recalls or regulatory action; manufacturing difficulties and delays; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of health care products and services; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in the company’s subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Neither the Johnson & Johnson Medical Devices Companies nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments.

¹ Stanbury, SJ, Voloshin, I. Reverse Shoulder Arthroplasty for Acute Proximal Humeral Fractures in the Geriatric Patient Geriatr Orthop Surg Rehabil. 2011 Sep-Nov; 2(5-6): 181–186.

² Gallinet D, et al. Improvement in shoulder rotation in complex shoulder fractures treated by reverse shoulder arthroplasty. J Shoulder Elbow Surg (2013) 22, 38-44.

³ Karageorgiou V, et al. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005;26:5474-91.

© DePuy Synthes 2018. All rights reserved.

SOURCE DePuy Synthes

Related Links

http://www.depuysynthes.com

May 22, 2018

WARSAW, Ind., May 21, 2018 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a call for applications for its second Connected Health Innovation Award. The Company is accepting applications from individuals, groups and organizations — including academia and industry — from all countries within Europe, the Middle East and Africa (EMEA) region. The award honors digital innovations that help solve unmet needs in the treatment of musculoskeletal and orthopaedic conditions. The winner will receive a €25,000 prize, an opportunity to pilot the technology in one of Zimmer Biomet’s partner hospitals in Europe and to promote the product in Zimmer Biomet’s Connected Health Innovation Lounge in Switzerland for one year.

“The Connected Health Innovation Award has been created to accelerate innovation in the digital health space focused on improving patient outcomes and efficiency in musculoskeletal healthcare,” said Marc Vogels, Zimmer Biomet’s Vice President of Marketing for EMEA Reconstructive and Zimmer Biomet Signature Solutions. “We are excited to acknowledge talented entrepreneurs and provide start-ups the opportunity to impact the way we are going to provide patient care in the future.”

Application Process
Applications for the second Zimmer Biomet Connected Health Innovation Award must be submitted online at www.connectedhealthaward.com/apply by June 15, 2018. Applicants must have a market-ready product, have obtained any necessary regulatory approvals, have first users willing to act as a reference and be able to demonstrate the value and core functionality of the product beyond concepts, papers, sketches, mockups, designs, formula and patents.

Applications will be reviewed by a jury composed of chief executive officers from Europe’s leading orthopaedic and musculoskeletal healthcare facilities. The jury will select five finalists. Finalists will be announced by June 30, 2018, and invited to the Zimmer Biomet EMEA headquarters in Switzerland to present their innovations and compete for the Award on July 10, 2018. Applications and additional information are available at http://www.connectedhealthaward.com.

About Zimmer Biomet
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.

We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Cautionary Statement Regarding Forward-Looking Statements
This release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet’s expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes.  Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially.  For a list and description of some of such risks and uncertainties, see Zimmer Biomet’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC).  These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet’s filings with the SEC.  Forward-looking statements speak only as of the date they are made, and Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.  Readers of this release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this release.

ZBH-Corp

SOURCE Zimmer Biomet Holdings, Inc.

Related Links

http://www.zimmer.com